Therefore, we hypothesize that overexpression of NKX2-1 or activation of PI3K signaling contributes to maintaining high level of ROR1 in CRC patients, which, however, needs further in-depth study to verify in the future. The gene discussed is ROR1; the disease is colorectal carcinoma.